PubMed Commons Opens Up Scientific Articles To User Comments 27
New submitter smegfault writes "In a new trial, PubMed Commons has been released. Until now, post-peer-publication results were restricted to letters to the editor of scientific journals; and even then some journals don't accept letters to the editor. With PubMed Commons, scientific peers can comment on PubMed-indexed articles without the interference of journal editors and peer reviewers. At the moment, eligible for participating are: 'Recipients of NIH (US) or Wellcome Trust (UK) grants can go to the NCBI website and register. You need a MyNCBI account, but they are available to the general public. If you are not a NIH or Wellcome Trust grant recipient, you are still eligible to participate if you are listed as an author on any publication listed in PubMed, even a letter to the editor. But you will need to be invited by somebody already signed up for participation in PubMed Commons. So, if you have a qualifying publication, you can simply get a colleague with the grant to sign up and then invite you.' However, reports are in that anyone with a PubMed / NCBI account can sign up on the PubMed home page."
Popular Science just decided to do the reverse (Score:4, Informative)
Re:what this will look like: (Score:5, Informative)
PLoS has had comments for a long time, and the result is - mostly no comments at all. I suspect the problem is that you're posting in your professional capacity, under your real name. That means you can really hurt your reputation with an off-hand comment; on the other hand, they count for nothing as far as your CV and employment prospects are concerned.
Posting a comment is really a losing proposition, with no upside (you can always contact the first author directly with questions) and potential downsides. So people, rationally, don't comment. Unless PubMed has figured out a way around it, I suspect this will be the end result this time around as well.
Re:what this will look like: (Score:4, Informative)
PLoS has had comments for a long time, and the result is - mostly no comments at all. I suspect the problem is that you're posting in your professional capacity, under your real name. That means you can really hurt your reputation with an off-hand comment; on the other hand, they count for nothing as far as your CV and employment prospects are concerned.
Posting a comment is really a losing proposition, with no upside (you can always contact the first author directly with questions) and potential downsides. So people, rationally, don't comment. Unless PubMed has figured out a way around it, I suspect this will be the end result this time around as well.
Quite. When you look at the way scientists behave in public you see that they're usually very cautious about criticising another's work. For example, questions following a talk at a meeting are usually very tame, even if the talk has glaring holes in it. It's karma in action: it's in everyone's interest to be nice in public because everyone gets up on the podium eventually and they want an easy ride when they're there. Also, the purpose of a talk at a meeting isn't to get grilled but to share data. Talks within an institute can get more rough if there's an ass in the audience whose feathers get ruffled. Similarly, people might be more forthright at a poster at a conference, where the interaction is more direct and fewer ears are listening in. Interactions by e-mail have, in my experience, been very diplomatic indeed.
There are plenty of shitty papers in my field that end up in the very top journals because the lead author won a Nobel and knows the editors, etc. Whilst it would feel great to see the opinions of the rest of the field nailed to the wall, nobody will benefit and it will only hurt the PhD student or postdoc who's first author.